Related Articles
A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer
A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation
Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer Corrigendum in /10.3892/mco.2021.2247
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
PREOPERATIVE CHEMOIMMUNOTHERAPY WITH CARBOPLATIN, EPIDOXORUBICIN, 5-FLUOROURACIL AND ALPHA-2B INTERFERON IN LOCALLY ADVANCED INOPERABLE GASTRIC-CANCER